Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Bleomycin/Cisplatin/Etoposide

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Alam S, et al. Retroperitoneal Lymph Node Dissection (RPLND) in Testicular Cancer: Emerging Surgical Issue to Offer Cure. European Urology Open Science 57 (Suppl. 1): S265 abstr. P187, Nov 2023. Available from: URL: https://dx.doi.org/10.1016/S2666-1683%2823%2901481-7 [abstract] Alam S, et al. Retroperitoneal Lymph Node Dissection (RPLND) in Testicular Cancer: Emerging Surgical Issue to Offer Cure. European Urology Open Science 57 (Suppl. 1): S265 abstr. P187, Nov 2023. Available from: URL: https://dx.doi.org/10.1016/S2666-1683%2823%2901481-7 [abstract]
Metadaten
Titel
Bleomycin/Cisplatin/Etoposide
Lack of efficacy
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56733-4

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Pembrolizumab

Case report

Rituximab

Case report

Mexiletine